CEO of Hyphens Pharma International, Lim See Wah, did not start the company from scratch. First, he worked there. Fresh out of the National University […]
Category: Hyphens Pharma
Singapore’s leading specialty pharmaceutical and consumer healthcare group
Hyphens Pharma takes full ownership of Ardence Pharma in RM15.9 million final tranche
Hyphens Pharma has completed the acquisition of the remaining 18% shareholding in Ardence Pharma Sdn Bhd, comprising 36,000 Tranche 3 Sale Shares, for a total […]
Hyphens Pharma takes Cerapro® to Europe in Louis Widmer tie-up
Hyphens Pharma has granted Swiss dermatology house Louis Widmer SA the rights to commercialise its Cerapro® MED Skin Barrier Cream across six European countries: Switzerland, […]
Hyphens Pharma extends Metoject reach to Thailand and Cambodia in deepening medac partnership
Hyphens Pharma has extended its partnership with Germany’s medac to include Thailand and Cambodia for the commercialisation of the Metoject subcutaneous autoinjector pen. The territory […]
Hyphens Pharma brings first new acne molecule in 40 years to Southeast Asia
Hyphens Pharma has launched Winlevi® (clascoterone) cream 1% in Singapore and Malaysia, marking the novel acne treatment’s first entry into Southeast Asia. The launch follows […]
Hyphens Pharma Secures Exclusive Rights to Commercialize Metoject® Auto-Injector in Southeast Asia
Singapore, 11 March 2025 – Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical group, has entered into an exclusive agreement with Germany’s medac GmbH to commercialize […]
Hyphens Pharma Reports Record FY2024 Results with 26.5% Net Profit Growth and 74% Dividend Increase
Singapore, 25 February 2025 – Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, today announced outstanding financial results for FY2024, achieving record […]
Hyphens Pharma Reports Steady Growth in Q3 2024 with 22.1% Revenue Increase for Nine-Month Period
Singapore, 12 November 2024 – Hyphens Pharma Limited, a leading specialty pharmaceutical and consumer healthcare company, today announced its financial results for the third quarter and […]
Hyphens Pharma launches Ceradan® Advanced Hand Balm specially for hand eczema
Hyphens Pharma Limited, Singapore’s leading specialty pharmaceutical and consumer healthcare group, launched its Ceradan® Advanced Hand Balm, the latest addition to its Ceradan® line for […]
Hyphens Pharma 1H2024 net profit jumps 66.7% to S$5.9 million
Hyphens Pharma Limited reported 1H2024 revenue grew by 33.4% to S$99.6 million in 1H2023 with all three business segments contributing to the growth. Revenue from […]